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Background: Self-monitoring of blood glucose (SMBG) helps to improve glycemic control 
and empowerment of people with diabetes. It is particularly useful for people with diabetes who 
are using insulin as it facilitates insulin titration and detection of hypoglycemia. Despite this, 
the uptake of SMBG remains low in many countries, including Malaysia.
Purpose: This study aimed to explore the barriers and facilitators to SMBG, in people with 
type 2 diabetes using insulin.
Patients and methods: Qualitative methodology was employed to explore participants’ 
experience with SMBG. Semistructured, individual in-depth interviews were conducted on 
people with type 2 diabetes using insulin who had practiced SMBG, in the primary care clinic 
of a teaching hospital in Malaysia. Participants were purposively sampled from different age 
groups, ethnicity, education level, and level of glycemic control (as reflected by the glycated 
hemoglobin [HbA
1c
]), to achieve maximum variation in sampling. All interviews were conducted 
using a topic guide and were audio-recorded, transcribed verbatim, checked, and analyzed using 
a thematic approach.
Results: A total of 15 participants were interviewed, and thematic saturation was reached. The 
factors that influenced SMBG were mainly related to cost, participants’ emotion, and the SMBG 
process. The barriers identified included: frustration related to high blood glucose reading; 
perception that SMBG was only for insulin titration; stigma; fear of needles and pain; cost of test 
strips and needles; inconvenience; unconducive workplace; and lack of motivation, knowledge, 
and self-efficacy. The facilitators were: experiencing hypoglycemic symptoms; desire to see the 
effects of dietary changes; desire to please the physician; and family motivation.
Conclusion: Participants’ perceptions of the purpose of SMBG, the emotions associated with 
SMBG, and the complexity, pain, and cost related to SMBG as well as personal and family 
motivation are the key factors that health care providers must consider when advising people 
with diabetes on SMBG.
Keywords: blood glucose self-monitoring, diabetes mellitus, in-depth interviews, qualitative 
study
Introduction
Self-monitoring of blood glucose (SMBG) is a tool that enhances self-care among 
people with diabetes.1 SMBG improves empowerment in those with diabetes, enabling 
them to assess the effects of lifestyle changes and medications on their blood glucose 
levels.2,3 Consequently, SMBG allows people with diabetes to undertake the necessary 
interventions to help improve their health outcomes.3 For people with type 2 diabetes 
using insulin, the benefit of SMBG in improving glycemic control is well established.4 
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SMBG helps people with diabetes to detect hypoglycemia 
and to adjust their insulin dosage appropriately.1,3,5
Despite SMBG being highly recommended in people 
with diabetes using insulin,3,5,6 its utilization remains low. 
Two Australian studies reported that 88.4% and 81.7% 
of those with diabetes using insulin practiced SMBG.7,8 
Such high prevalence of SMBG use may be attributed 
to the subsidies for test strips provided by the federal 
government since 1987.7 However, in the United States 
of America and Italy, it was found that only a minority 
of those with diabetes using insulin (26% and 13.9%, 
respectively) practiced at least daily SMBG, even though 
the monitoring devices are provided free in Italy.9,10 In 
Hungary, only 20% of people with diabetes were found 
to practice daily SMBG. Those using insulin were reim-
bursed for SMBG.11
In Asian countries, such as Korea, only 32% of people 
with type 2 diabetes were shown to practice SMBG regu-
larly,12 but in China, 39.5% of those with type 2 diabetes were 
shown to practice SMBG at least once monthly.13 However, 
these studies did not specify the utilisation pattern of SMBG 
among those using insulin.
In Malaysia, it was shown that only 6.9% and 26.8% of 
people with diabetes in private clinics and public hospitals, 
respectively practiced SMBG. On an average, these people 
monitored their blood glucose levels about eleven times a 
month.14,15 Another study reported similar findings, with only 
15.3% of people with type 2 diabetes practicing SMBG.16 
This study also found that the use of insulin was one of the 
predictors for SMBG, but the utilisation pattern of SMBG 
among those on insulin was not reported.
Quantitative studies have identified several barriers to 
the practice of SMBG among people with diabetes. These 
include advancing age, lower education level and income 
group, fewer comorbidities, fear of testing and pain, and 
lack of physician support or visits.10,16,17 In addition, a num-
ber of qualitative studies have described reasons for SMBG 
underutilization, such as distressing emotions and thoughts, 
fingertip pain, discouragement and frustration about “poor” 
blood glucose reading, lack of awareness of hypoglycemia 
and hyperglycemia, lack of social support, and difficulty in 
interpreting SMBG results.18−20
Most of the studies either focused on people with type 2 
diabetes who were not using insulin, included both people 
with type 1 and type 2 diabetes, or broadly discussed self-
management care but not specifically SMBG. Thus far, 
there are few studies in Malaysia focusing on the attitudes 
on SMBG held by people with type 2 diabetes using insulin, 
the reasons for the adoption or not of SMBG, or on how 
SMBG is incorporated into the self-management of diabetes. 
Given the well-established benefits of SMBG among people 
with type 2 diabetes using insulin and the recommendation 
for these people to engage in SMBG by both international1,3,5 
and local6 guidelines, a study on this population is of utmost 
importance.
Therefore, this study aimed to explore the barriers and 
facilitators to SMBG in people with type 2 diabetes using 
insulin. Understanding the attitudes and reasons underlying 
their behavior can provide valuable insights into the rationale 
for the practice of SMBG and its perceived benefits. This 
may help health care providers and the authorities concerned 
to improve the utilization of SMBG in this group of people 
with type 2 diabetes, who require more stringent glycemic 
control.
Patients and methods
A qualitative methodology was employed to explore par-
ticipants’ experience in SMBG. This approach allows the 
researchers to obtain more in-depth information concern-
ing the participants’ attitudes on SMBG.21 In this study, 
individual in-depth interviews were conducted to enable 
participants to express their personal views and preferences 
on SMBG more freely. Focus group discussions were not 
adopted because participants, conscious of how the others 
present in the group might think of them, might have felt 
restricted in expressing their opinion freely.
Participants were recruited from a primary care clinic of 
the University Malaya Medical Centre, an urban teaching 
hospital in Malaysia. The number of participants recruited 
was based on data saturation, that is, data collection was 
stopped when no new theme emerged from the interviews.21 
People who were eligible for participation included those 
who were 21 years and above, were diagnosed with type 2 
diabetes, were currently using insulin with or without oral 
hypoglycemic agents, and who had practiced SMBG. People 
who were diagnosed with type 1 or gestational diabetes, 
or unable to understand English, Malay or the Chinese dialect 
Cantonese, were excluded.
Purposive sampling was used whereby the selection of 
participants was focused on maximum variation sampling 
in terms of age group, ethnicity, education level, and level 
of glycemic control, as reflected by the glycated hemo-
globin (HbA
1c
) level. This sampling method was intended 
to increase the likelihood that participants interviewed 
would provide a range of views and experiences in using 
SMBG.21
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Participants were recruited and interviewed between 
January and June 2013. A researcher screened patients’ 
medical records before their clinic appointments, and those 
who met the inclusion criteria were enlisted. On the day of 
the clinic appointments, those selected were invited to par-
ticipate in the study. When a person agreed to participate in 
the study, a Participant Information sheet was given, and the 
participant signed an informed consent declaration before 
commencement of the in-depth interview. The participant’s 
demographic and relevant clinical data were obtained and 
recorded using a data collection form. This study was 
approved by the Medical Ethics  Committee  (reference num-
ber 956.13) of the University Malaya  Medical Centre.
A semistructured interview topic guide (Table 1) was 
developed based on the literature, conceptual framework 
(Figure 1), and experts’ opinions. Conceptual framework 
was drawn from the literature while the experts in this study 
comprised experienced researchers. Most of the questions 
were open-ended to encourage participants to provide in-
depth information. Prompts were used only if the participants 
did not raise the key issues spontaneously.
A pilot study was conducted with two participants to 
ensure that the questions were clear and relevant. This also 
helped the researcher to become familiar with the study 
procedure. The two researchers who conducted the inter-
views had no prior professional contact with the participants. 
The pilot study showed that the topic guide was suitable for 
subsequent interviews. Therefore, the interview procedure 
and topic guide were maintained with minimal amendment, 
and the data obtained were included in the analysis.
A total of 24 people with diabetes (including two partici-
pants from the pilot study) were approached. The reasons for 
nonparticipation included no interest (n=4), language barrier 
(n=3), and time factor (n=2).
All the in-depth interviews were carried out by the same 
researcher, in a private room to ensure confidentiality.21 
After each interview the researcher reflected and made notes 
on the interview. This helped to identify any personal biases 
and experiences that may have influenced the interviews and 
interpretation of the data. Each interview lasted between 
16 and 41 minutes. All interviews were audio-recorded and 
transcribed verbatim. Four transcripts that were in Cantonese 
were transcribed and translated by an independent person who 
was proficient in both Cantonese and English. All transcripts 
were checked independently for accuracy and then used as 
data for analysis.
A thematic analysis was carried out through constant 
comparison across transcripts. The researchers familiarized 
themselves with the data by reading the transcripts repeatedly 
to identify key ideas and recurrent codes.21 Three researchers 
coded the first two transcripts independently and created a list 
of themes. The remaining transcripts were coded by one of the 
researchers. Any new theme that emerged was added to the list 
upon consultation with the other researchers; the new codes were 
then categorized and merged to form larger concepts. The coding 
was compared for consistency, to minimize any biases as well 
as to enhance data credibility. Any coding discrepancies were 
resolved through discussion until consensus was achieved. The 
data obtained were managed using an open-source, computer-
assisted qualitative data analysis software, Text Analysis Markup 
System (TAMS) Analyzer (Matthew Weinstein, University of 
Washington-Tacoma, Tacoma, WA, USA).
One of the researchers is a family medicine physician 
and academician; another is an experienced pharmacist 
and  academician. The third researcher is an experienced 
 pharmacist and postgraduate candidate.
Results
Finally, 15 participants were included in this study. The demo-
graphic and clinical background of the participants are pre-
sented in Table 2. The list of themes that influenced the practice 
of SMBG is summarized in Table 3. Participant quotations 
were cited verbatim, after translation (where appropriate).
Barriers to sMBg
Participants highlighted a range of perceived barriers to 
their utilization of SMBG. These included the cost of test 
strips and needles; frustration related to high blood glucose 
reading; perception that SMBG was only for insulin titration; 
stigma; fear of needles and pain; inconvenience; unconducive 
workplace; lack of motivation; and lack of knowledge and 
self-efficacy.
Table 1 summary of interview topic guide on barriers and facili-
tators to sMBg
•  how did you start testing your blood sugar at home? Who advised 
you? Why do you need to do the test?
 ○ Physician, pharmacist, diabetes nurse, family, friends, self
• how often do you test your blood sugar at home?
•  What is your physician’s recommendation on testing frequency? Do 
you follow? Why?
• Are there times that you stop testing or test more often? Why?
 ○ sick, travel, fasting, special occasion, work
•  What do you understand about your blood sugar reading at home? 
What do you do with the reading?
•  What difficulties or problems did you encounter? How and why?
• What kind of help do you need to overcome these barriers?
Abbreviation: sMBg, self-monitoring of blood glucose.
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one day and said, you know, “What’s the point I buy the 
meter for you and you don’t use it?” And I said ‘The strips 
are so expensive,” you know, “Where do you want me to 
get the money?” [P01, 57-year-old female clerk, diabetes 
for 17 years]
I cannot simply check every day, because err, the thing 
[test strip] is also expensive. We need to buy the strips, we 
need to buy the needles, unless if I get it free then it doesn’t 
matter. I don’t mind checking it every day [participant 
laughed]. [P07, 45-year-old male credit officer, diabetes 
for 4 years]
Frustration related to high blood glucose reading
SMBG can be a very challenging and frustrating task for 
some participants. High blood glucose readings affected 
Table 2 Participants’ demographic and clinical background
Characteristics Number of 
participants (%)
n 15
Age (years), mean ± sD (range) 58.7±14 (23–83)
sex 
  Male 
Female
 
8 (53) 
7 (47)
ethnicity 
  Malay 
chinese 
indian
 
3 (20) 
6 (40) 
6 (40)
Marital status 
  single 
Married 
Widower
 
2 (13.3) 
11 (73.4) 
2 (13.3)
highest level of education 
  none 
Primary school 
secondary school 
Diploma 
Undergraduate degree 
Undisclosed*
 
1 (6.6) 
2 (13.3) 
7 (47) 
3 (20) 
1 (6.6) 
1 (6.6)
Duration of diabetes (years), mean ± sD (range) 14.1±7.6 (1–30)
Duration of sMBg, mean ± sD (range) 3.4±2.8 years  
(2 months–10 years)
hbA1c level, mean ± sD (range)† 
  % 
mmol/mol
 
8.4±1 (6.4–9.6) 
68.7±10.7 (46–81)
Notes: *Participant refused to disclose the information; †participants’ latest value at 
the time of interview.
Abbreviations: hbA1c, glycated hemoglobin; sD, standard deviation; sMBg, self-
monitoring of blood glucose.
Table 3 Barriers and facilitators to sMBg by people with type 2 
diabetes using insulin
Barriers • cost of test strips and needles
•  Frustration related to high blood glucose 
reading
•  Perception that sMBg was only for insulin 
titration
• stigma
• Fear of needles and pain
• inconvenience
• Unconducive workplace
• lack of motivation
• Lack of knowledge and self-efficacy
Facilitators • experiencing hypoglycemic symptoms
• Desire to see the effects of dietary changes
• Desire to please the physician 
• Family motivation
Abbreviation: sMBg, self-monitoring of blood glucose.
SMBGCost Education 
Reliability 
Ease of use 
Social support
Attitude Awareness Lifestylea
Knowledge 
Skills 
Health status
Patient
Health care
provider
Equipment 
Figure 1 Conceptual framework of factors influencing the use of SMBG.
Note: alifestyle includes diet, exercise, travel, fasting and work.
Abbreviation: sMBg, self-monitoring of blood glucose.
cost of test strips and needles
The cost for SMBG was the main reason why participants 
did not practice SMBG regularly.
Because, you know, the strips are very expensive, so I 
seldom do it like err until she [the daughter] shouted at me 
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participants negatively, and some might even stop SMBG 
altogether.
[If] It’s a bit 1, 1, 2 [mmol/L] more, I get frustrated. 
“Why is the blood glucose not coming down.” Ahh, that 
frustration. I pray hundred times, I pray, pray, pray, [that 
it] must not be more than this, must not be, still I prick 
and see “Oh, it is more than that,” I worked out. Before 
that sickness kills me, the mental torture will kill me. 
Ahh, that’s why I just couldn’t be bothered [to practice 
SMBG]. [P14, 61-year-old female retiree, diabetes for 
20 years]
Participants also stated that they would omit SMBG if 
they expected their blood glucose levels to be high owing to 
lack of dietary control.
During December nothing [SMBG not done], I dare not 
[participant laughed], I dare not check, because I was also 
eating sweets. I was also having a little bit of wine, how 
do you test your sugar level [participant laughed], when 
you drink wine? [P01, 57-year-old female clerk, diabetes 
for 17 years]
Participants also felt that carrying the glucose meter along 
when travelling was depressing and hence, tended to leave 
the meter behind.
December, I seldom check and I was away from the 
country also for a holiday. So, I let myself go during that 
time actually, don’t want to carry the strip, I mean the 
testing machine around to, you know to depress myself 
[participant giggled]. [P01, 57-year-old female clerk, 
diabetes for 17 years]
Perception that sMBg was only for insulin titration
Participants believed that the main purpose of SMBG was 
to establish the correct insulin dose. Once the dose was 
 “stabilized,” participants were less likely to practice SMBG.
I, I used it [SMBG] for a while then I stopped [participant 
giggled] because I’ve achieved, err, my dosage level. For 
a start, it’s [SMBG] helpful but once you have established 
yourself, your insulin is stabilized, then I think you can 
just do it less frequently. [P09, 62-year-old male retiree, 
diabetes for 7 years]
stigma
Participants may have perceived the practice of SMBG as a 
stigma, and hence, they were reluctant to practice SMBG in 
the presence of other people.
You go travelling and other people can see [participant 
laughed]. I don’t dare to tell other people I have to do all 
these [SMBG]. I don’t dare to tell [participant giggled], 
not nice to let other people know. [P08, 48-year-old female 
housewife, diabetes for 1 year]
Fear of needles and pain
Participants found the fingertip pricking painful and hence 
did not practice SMBG that frequently.
Once you prick, you will still jump a bit. Whoever says no 
pain is faking it. If I test every day, my fingers will have 
many holes, very painful. [P08, 48-year-old female house-
wife, diabetes for 1 year]
inconvenience
Participants felt that SMBG was a cumbersome procedure, 
and this had impeded their SMBG, even at home. This is 
probably because they were using the older, bulkier glucose 
meters.
No, my glucose meter is not user-friendly and it is a bigger 
thing, is a big box. It affects me, taking it out, putting it back, 
you see. I need a special place for myself. [P06, 69-year-old 
female retiree, diabetes for 15 years]
Unconducive workplace
Workplace that is unconducive also seemed to hinder 
SMBG.
I work at the workshop. Hands are dirty. I have to run there, 
run here. I won’t do the test at the corner of my workplace. 
Troublesome. That’s the problem. But if I work in the 
office, everything is possible. I’m afraid my workplace 
has germs. [P11, 52-year-old male police officer, diabetes 
for 20 years]
lack of motivation
Participants reported that they were “very keen” and “hard-
working” in practicing SMBG at the beginning. They did it 
conscientiously, based on their physicians’ or diabetes educa-
tors’ recommendations. However, they lost their motivation 
over time.
Beginning yes, beginning very keen, now no. I’m just sim-
ply lazy to do it. [P06, 69-year-old female retiree, diabetes 
for 15 years]
Lack of knowledge and self-efficacy
Participants often considered frequent SMBG as unneces-
sary, and this caused them to change the way they monitored 
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their blood glucose levels based on their own perceived 
needs.
When I first started [SMBG], I tried three times a day. 
Before breakfast, before lunch, before dinner. I feel that it 
doesn’t serve purpose. I practiced this [three times a day] 
only once. I said to myself, “For what? The blood sugar 
will surely rise after meals.” That’s why I only monitor 
once every morning now. [P13, 62-year-old male retiree, 
diabetes for 15 years]
Participants felt overwhelmed by the instructions to 
practice SMBG and had to rely on others to do the SMBG 
for them.
He [husband] helps me, helps me to test the blood sugar, 
helps me to inject insulin at night. I can’t do it on my own.  
I don’t have the mood to learn. I already have many illnesses 
[participant laughed]. I need to remind him to test for me. 
Sometimes I keep thinking, “I don’t want to ask him.” I’m 
very lazy, very lazy and I didn’t test. [P12, 71-year-old 
female housewife, diabetes for 30 years]
Facilitators to sMBg
Facilitators that encouraged participants to practice SMBG 
include: experiencing hypoglycemic symptoms; desire to see 
the effects of dietary changes; desire to please the physician; 
and family motivation.
experiencing hypoglycemic symptoms
Participants cited that they were more likely to practice 
SMBG when they experienced symptoms, which included 
tiredness, giddiness, uneasiness, and body ache.
Blood sugar monitoring helps me to control my sugar, you 
know. Sometimes, when I feel very giddy, I will check 
my sugar level and when it’s high, you know, I control 
my food. It helps me to control my food and all that. 
[P03, 55-year-old male administrative officer, diabetes 
for 5 years]
Desire to see the effects of dietary changes
Participants reported that they practiced SMBG to check the 
effects of food on their blood glucose levels.
When I go for buffet lunch and eat a lot of rubbish, I didn’t 
know what I was eating. Then I get scared, I go back, 
test my sugar [participant laughed]. That’s why I tested 
sometimes. [P06, 69-year-old female retiree, diabetes 
for 15 years]
Participants reported that they were prompted to practice 
SMBG to check the effects of new types of food that they 
had consumed.
Like after you have eaten a certain food, which you have 
not eaten before. Once eaten then you need to test, the 
next morning you need to test. To see if the blood sugar 
level is high. [P04, 83-year-old male retiree, diabetes for 
18 years]
Desire to please the physician
Participants claimed that they would “behave” and practice 
SMBG according to their physicians’ recommendations when 
their appointment dates were approaching. This is because 
participants wanted to show their physicians the “good” SMBG 
results so that their insulin dose could be decreased or they 
could have a longer interval before their next appointment.
I have been using it [SMBG] every day because I know 
I have got an appointment coming up, so I better behave 
[participant giggled]. So that I can tell the doctor, you know, 
I want to bring down the insulin dose. [P01, 57-year-old 
female clerk, diabetes for 17 years]
Family motivation
Support from family members motivated participants to 
practice SMBG.
My daughter used to make noise. “Do you know what’s 
your sugar level?” I said “How am I supposed to know? 
I don’t have a meter to test.” [participant giggled]. That’s 
why she purchased it for me. [P01, 57-year-old female clerk, 
diabetes for 17 years]
Discussion
Main findings and comparisons  
with other studies
Most participants perceived cost as the most important barrier 
to SMBG, a finding similar to that of other studies.12,22,23 In 
Malaysia, there are no subsidies for test strips and needles.24 
Even when test strips were reimbursed in the United States 
of America, people with diabetes still reported that SMBG 
was costly.18 Higher costs have been associated with poor 
adherence to SMBG.25,26 It has been reported that the costs 
associated with diabetes complications,27,28 and the number 
and overall duration of hospitalizations29 for people with 
diabetes were significantly reduced among SMBG users 
compared with non-SMBG users. Therefore, an increase in 
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SMBG utilization among insulin users, besides improving 
glycemic control, would help to save some health care costs 
in the long-term. Subsidies for test strips and needles would 
help to ease the financial burden for people with diabetes, 
and this would increase their adherence to SMBG.30
Obtaining higher than normal blood glucose readings 
elicited feelings of frustration and discouragement, leading 
to decreased motivation among people with diabetes and 
nonadherence to SMBG.31 Likewise, negative thoughts that 
were shown to interfere with SMBG include not wanting to 
know the results when the blood glucose levels were likely 
to be high.18,32 Such thoughts may lead to denial or indiffer-
ence, when those with diabetes interpret high blood glucose 
readings as poor control.19 These findings suggest that inter-
ventions by health care providers are required to help people 
with diabetes cope with negative feelings and to prevent these 
from influencing their decision to practice SMBG.
The perception that SMBG is solely for insulin titration 
could be a concern. Therefore, it is recommended that health 
care providers improve awareness in people with diabetes 
through appropriate education regarding the other benefits of 
SMBG in diabetes control. Group diabetes education should 
be considered as this has been shown to increase adherence 
to SMBG.7
People with diabetes have reported that stigma is a 
significant concern to them.33 This probably causes tension 
and anxiety, leading to suboptimal SMBG. Another study 
found that some people discriminated against people with 
diabetes who injected insulin in public, equating them to 
addicts or users of illegal drugs. People with diabetes who 
were recipients of discrimination tended to omit SMBG 
and delayed their insulin injections.34 This fear of practic-
ing SMBG in front of other people could be minimized via 
education and support, through counseling and peer support 
groups, which may help to reduce the emotional impact of 
stigma and enhance coping.33
Although the needles used for SMBG nowadays are 
relatively fine,35 anxieties over the use of needles and pain 
may still occur and lead to decreased adherence to SMBG.30,36 
Health care providers have to consider these factors when 
discussing SMBG with people with diabetes – they should 
be taught techniques for making the finger prick less painful, 
for instance, using the lateral side of the finger, avoiding use 
of the thumbs and index fingers, or using shallower needle 
depths;2 in addition, alternative-site testing such as the arm, 
abdomen, and thigh may be used to give the fingers a rest.1,35 
People with diabetes should also be counseled on the correct 
interpretation of their SMBG results.
The finding that SMBG was inconvenient is consistent 
with other studies that also described SMBG procedure as 
inconvenient and difficult, leading to poor adherence to 
SMBG.2,25,26 However, with the advancement of technology, 
the testing process has been greatly improved and simplified, 
hence, more convenient to manage.37
Some participants perceived their workplace as unsuit-
able for SMBG and found it troublesome to practice SMBG 
outside their homes. This finding is in accordance with that of 
another study.25 This barrier could be resolved by educating 
people with diabetes regarding suitable areas and times for 
practicing SMBG. A clean room is not necessary for practic-
ing SMBG, but the person must be able to clean their hands 
properly before pricking their own fingers. The benefits of 
regular SMBG should be emphasized as studies have shown 
improvement in adherence to SMBG through education and 
self-management training.7,19
Self-motivation facilitated the practice of SMBG for 
participants in this study, but they were not able to sustain 
such motivation. Some participants attributed this to laziness. 
This finding corresponds to that of other studies.36,38 Simple 
diabetes education has been found to be sufficiently moti-
vational and to improve the frequency of SMBG.7,36 Thus, 
health care providers can reinforce the commitment of those 
with diabetes to conduct SMBG by discussing their SMBG 
results so that they are keen to practice SMBG to monitor 
their glycemic control.
Most participants in this study were educated (secondary 
school and higher). Education might have influenced their 
understanding and knowledge of the importance of SMBG. 
It was suggested that people with diabetes who were less 
informed about their disease and plan of care would be less 
likely to practice SMBG.12,38,39 On the other hand, those with 
diabetes who received information about SMBG felt empow-
ered.18,19 It was shown that an empowerment-based diabetes 
self-management support intervention, consisting of weekly 
educational newsletters coupled with clinical feedback from 
the health care providers, significantly improved the practice 
of SMBG.40 Close follow-up by health care providers may 
also help to enhance adherence to SMBG.1
Studies have shown that people with diabetes who expe-
rienced hypoglycemic events were more likely to practice 
SMBG to confirm their symptoms so that appropriate actions 
could be taken.18,36,41 Most participants in this study assumed 
that dizziness is a hypoglycemic symptom, but dizziness may 
indicate episodes of hypoglycemia or hyperglycemia.1 It is 
possible that the episodes of both conditions may be identi-
fied incorrectly, leading to unnecessary fear or wrong action 
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being taken. Therefore, health care providers should provide 
clear explanations of how SMBG could help in determining 
the cause of dizziness (as opposed to basing this on mere 
conjecture).
Intake of large amounts of food or foods that were per-
ceived as “new” to participants prompted them to monitor 
their blood glucose levels. This is consistent with a previous 
study, in which people with diabetes practiced SMBG more 
often during dinner gatherings and festivities.39 This indicates 
that SMBG may help those with diabetes to understand the 
cause-and-effect relationship between food and blood glu-
cose levels, thus affirming one of the uses of SMBG stated 
in the guidelines, that is, the results of SMBG can be useful 
in adjusting dietary intake.3,6
The health care providers’ attention in responding to 
the blood glucose readings was one of the reasons some 
 participants gave for continuing SMBG. This, in turn, 
created participants’ interest in SMBG so that they could 
anticipate positive feedback on their glycemic control from 
their physicians. It was found that the lack of interest of 
health care providers in the United Kingdom contributed to a 
decrease in SMBG.20 Therefore, health care providers should 
discuss the SMBG results with those concerned, to encourage 
optimal use of SMBG. It has been suggested that continuous 
guidance and routine follow-up evaluation, of SMBG tech-
nique and of the ability of people with diabetes to respond to 
their readings appropriately, should be implemented.3
The finding of family motivation as a facilitator to 
SMBG practice was similar to that of other studies that 
found those with family support were more likely to practice 
SMBG.12,19,22,23 Encouragement and assistance from a family 
member or friend would foster more positive attitudes toward 
SMBG.19 Therefore, support, whether received emotionally 
or financially, empowers people with diabetes to be active 
in their self-care. Health care providers should facilitate 
support networks through empowerment interventions,40 to 
optimize SMBG use.
strengths and limitations
The sample comprised participants with a broad range of 
perspectives on SMBG. Thus, the researchers were able to 
gain an in-depth understanding of the experiences of people 
from different demographic backgrounds. Such informa-
tion can ensure that the barriers to SMBG can be addressed 
before, during, and even after SMBG initiation; further, the 
facilitators to SMBG can be employed during counseling, for 
enhancing empowerment in those with diabetes. The results 
of this study were based on self-reporting by  participants 
who had practiced SMBG. The views of people with dia-
betes using insulin who had never practiced SMBG were 
not explored. Future studies should explore the reasons for 
not practicing SMBG. This study was conducted in an urban 
teaching hospital in Malaysia, where participants have easy 
access to health care facilities. Therefore, the study findings 
may not be applicable to other settings where health care 
services are more limited. In addition, health care providers’ 
perceptions on SMBG should be explored in future studies. 
A quantitative approach with a large-scale survey, to deter-
mine how common the barriers or facilitators to SMBG are 
identified in the present study, would be required for the 
purpose of generalization.
Conclusion
The main benefit of SMBG is to help people with diabetes 
improve their glycemic control. In order to enhance adherence 
to SMBG, the barriers and facilitators to SMBG were 
explored through their perspectives. The findings of this 
study show that SMBG was practiced primarily to confirm 
symptoms and the effects of food intake rather than on a 
routine basis. Cost was a common barrier to SMBG.  Health 
authorities concerned should consider providing financial 
incentives to encourage more frequent monitoring of blood 
glucose levels. Participants’ perceptions of the purpose of 
SMBG, the emotions associated with SMBG, the complexity 
and pain related to SMBG, as well as personal and family 
motivation were the other key factors that health care pro-
viders must consider when advising people with diabetes to 
conduct SMBG.
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